CN104383297A - Medicine for treating migraine - Google Patents
Medicine for treating migraine Download PDFInfo
- Publication number
- CN104383297A CN104383297A CN201410597553.XA CN201410597553A CN104383297A CN 104383297 A CN104383297 A CN 104383297A CN 201410597553 A CN201410597553 A CN 201410597553A CN 104383297 A CN104383297 A CN 104383297A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- rhizoma
- medicine
- raw material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 29
- 208000019695 Migraine disease Diseases 0.000 title abstract description 10
- 206010027599 migraine Diseases 0.000 title abstract description 10
- 229940079593 drug Drugs 0.000 title description 8
- 239000002994 raw material Substances 0.000 claims abstract description 21
- 241001093152 Mangifera Species 0.000 claims description 13
- 241000131808 Scolopendra Species 0.000 claims description 13
- 239000010135 fructus aurantii immaturus Substances 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 8
- 230000001954 sterilising effect Effects 0.000 claims description 7
- 238000004659 sterilization and disinfection Methods 0.000 claims description 7
- 230000000694 effects Effects 0.000 abstract description 6
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 abstract 1
- 235000003097 Artemisia absinthium Nutrition 0.000 abstract 1
- 240000001851 Artemisia dracunculus Species 0.000 abstract 1
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 abstract 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 abstract 1
- 240000000113 Baeckea frutescens Species 0.000 abstract 1
- 235000004335 Baeckea frutescens Nutrition 0.000 abstract 1
- 235000004936 Bromus mango Nutrition 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 244000183685 Citrus aurantium Species 0.000 abstract 1
- 235000007716 Citrus aurantium Nutrition 0.000 abstract 1
- 241000675108 Citrus tangerina Species 0.000 abstract 1
- 244000150195 Cyperus longus Species 0.000 abstract 1
- 235000018109 Cyperus longus Nutrition 0.000 abstract 1
- 244000075634 Cyperus rotundus Species 0.000 abstract 1
- 241000305492 Gastrodia Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 241000234435 Lilium Species 0.000 abstract 1
- 240000007228 Mangifera indica Species 0.000 abstract 1
- 235000014826 Mangifera indica Nutrition 0.000 abstract 1
- 235000006751 Platycodon Nutrition 0.000 abstract 1
- 244000274050 Platycodon grandiflorum Species 0.000 abstract 1
- 235000005010 Scirpus paludosus Nutrition 0.000 abstract 1
- 241000207929 Scutellaria Species 0.000 abstract 1
- 235000009184 Spondias indica Nutrition 0.000 abstract 1
- 239000001138 artemisia absinthium Substances 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000008216 herbs Nutrition 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 229930189914 platycodon Natural products 0.000 abstract 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 abstract 1
- 206010019233 Headaches Diseases 0.000 description 11
- 231100000869 headache Toxicity 0.000 description 10
- 208000002193 Pain Diseases 0.000 description 7
- 239000002775 capsule Substances 0.000 description 7
- 230000036407 pain Effects 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 2
- 230000010349 pulsation Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 1
- 206010054956 Phonophobia Diseases 0.000 description 1
- 206010034960 Photophobia Diseases 0.000 description 1
- 208000001407 Vascular Headaches Diseases 0.000 description 1
- 206010047163 Vasospasm Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000002491 angiogenic effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000001314 paroxysmal effect Effects 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8988—Gastrodia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/648—Myriapods, e.g. centipedes or millipedes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/22—Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/237—Notopterygium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/89—Cyperaceae (Sedge family)
- A61K36/8905—Cyperus (flatsedge)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8967—Lilium, e.g. tiger lily or Easter lily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Insects & Arthropods (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicine for treating migraine. The medicine is prepared from the following raw materials in parts by weight: 10 to 20 parts of tall gastrodia tubers, 8 to 15 parts of immature bitter orange, 5 to 10 parts of mango roots, 5 to 10 parts of diverse wormwood herbs, 5 to 10 parts of cassia twigs, 5 to 10 parts of tangerine peels, 5 to 10 parts of baeckea frutescens, 1 to 10 parts of nutgrass galingale rhizomes, 6 to 14 parts of platycodon roots, 6 to 10 parts of angelicae sinensis, 8 to 12 parts of manyleaf paris rhizomes, 1 to 5 parts of scutellaria laterifolia, 1 to 5 parts of lily bulbs, 1 to 5 parts of notopterygium roots and 1 to 5 parts of liquorice. The medicine provided by the invention is used for treating migraine and has the advantages of quick and good curative effects and low recurrence rate, and is convenient to use.
Description
Technical field
The present invention relates to technical field of Chinese medicines, be specifically related to one and treat migrainous medicine.
Background technology
Migraine is vascular headache the most common, present the throbbing pain consistent with pulsation or distending pain, bow, be heated, firmly cough etc. headache all can be made to increase the weight of, show effect in acute recurrent.Migraine is often with symptoms such as Nausea and vomiting, photophobia, phonophobias, and patient's main clinical manifestation is head side or bilateral distending pain, in beating or rest pain, and periodical attack, unilateral headache during outbreak, and sharp ache sometimes, tool pulsation.At present, treat migrainous medicine a lot, but, mostly there is the defects such as effect is obvious not, cure rate is lower, treatment time is long, medical expense is high.
Summary of the invention
The technical problem to be solved in the present invention is to provide the migrainous medicine for the treatment of that a kind of curative effect is fast, good effect, relapse rate are low, easy to use.
For solving the problems of the technologies described above, the present invention by the following technical solutions:
One treats migrainous medicine, is made up of the raw material of following weight portion:
10 ~ 20 parts, Rhizoma Gastrodiae, Fructus Aurantii Immaturus 8 ~ 15 Fen, Fructus Mangifera Indicae root 5 ~ 10 parts, Herba Artemisiae Anomalae 5 ~ 10 parts, Ramulus Cinnamomi 5 ~ 10 parts, Pericarpium Citri Reticulatae 5 ~ 10 parts, Scolopendra 5 ~ 10 parts, Folium Baeckeae 1 ~ 10 part, Rhizoma Cyperi 1 ~ 10 part, Radix Platycodonis 6 ~ 14 parts, Radix Angelicae Sinensis 6 ~ 10 parts, Rhizoma Paridis 8 ~ 12 parts, Radix Scutellariae 1 ~ 5 part, Bulbus Lilii 1 ~ 5 part, Rhizoma Et Radix Notopterygii 1 ~ 5 part, 1 ~ 5 part, Radix Glycyrrhizae.
As one of preferred, the weight portion of described raw material is:
10 parts, Rhizoma Gastrodiae, Fructus Aurantii Immaturus 9 Fen, Fructus Mangifera Indicae root 10 parts, Herba Artemisiae Anomalae 6 parts, Ramulus Cinnamomi 8 parts, Pericarpium Citri Reticulatae 10 parts, Scolopendra 5 parts, Folium Baeckeae 6 parts, Rhizoma Cyperi 10 parts, Radix Platycodonis 6 parts, Radix Angelicae Sinensis 8 parts, Rhizoma Paridis 11 parts, Radix Scutellariae 1 part, Bulbus Lilii 3 parts, Rhizoma Et Radix Notopterygii 5 parts, 1 part, Radix Glycyrrhizae.
As one of preferred, the weight portion of described raw material is:
15 parts, Rhizoma Gastrodiae, Fructus Aurantii Immaturus 15 Fen, Fructus Mangifera Indicae root 5 parts, Herba Artemisiae Anomalae 8 parts, Ramulus Cinnamomi 9 parts, Pericarpium Citri Reticulatae 5 parts, Scolopendra 8 parts, Folium Baeckeae 9 parts, Rhizoma Cyperi 1 part, Radix Platycodonis 11 parts, Radix Angelicae Sinensis 10 parts, Rhizoma Paridis 8 parts, Radix Scutellariae 3 parts, Bulbus Lilii 5 parts, Rhizoma Et Radix Notopterygii 1 part, 3 parts, Radix Glycyrrhizae.
As one of preferred, the weight portion of described raw material is:
18 parts, Rhizoma Gastrodiae, Fructus Aurantii Immaturus 8 Fen, Fructus Mangifera Indicae root 8 parts, Herba Artemisiae Anomalae 10 parts, Ramulus Cinnamomi 5 parts, Pericarpium Citri Reticulatae 8 parts, Scolopendra 10 parts, Folium Baeckeae 2 parts, Rhizoma Cyperi 7 parts, Radix Platycodonis 13 parts, Radix Angelicae Sinensis 6 parts, Rhizoma Paridis 10 parts, Radix Scutellariae 5 parts, Bulbus Lilii 1 part, Rhizoma Et Radix Notopterygii 3 parts, 5 parts, Radix Glycyrrhizae.
Preparation method: by above-mentioned raw materials mixer mill powdered, after ultraviolet sterilization process, namely obtain after incapsulating, every capsules is containing 0.5 ~ 1 gram of crude drug.
Using method: oral, every day three times, each capsules seven days is a course for the treatment of.
Medicine of the present invention has that nourishing the liver is dispeled the wind, sensible effect of invigorating blood circulation, its compatibility science, mild in medicine property and, cephalagra can be alleviated rapidly, promote vasodilation, mechanism in control agent, excited inherent analgesia system, remove vasospasm, anticoagulant and angiogenic substance release, make disease rehabilitate.Prove through the routine applicable cases of clinical patients 100, cure rate 89%, effective percentage 8%.Wherein, a few example typical clinical practice example is as follows:
Example 1,5 so-and-so, man, 38 years old, people from Guilin, have a headache 2 years, sometimes feels sick, sustainable 1 day of pain, red tongue, and body is bigger, tongue in vain, stringy pulse.After taking 1 course for the treatment of of the present invention, headache relief, tongue body is bigger, and tongue is white, stringy pulse; After continuing to take 1 course for the treatment of, migraine heals entirely, recurrence that so far there are no.
Example 2, what so-and-so, female, 43 years old, often there is paroxysmal headaches in people from Guilin, is 1 hour at every turn.After taking 3 courses for the treatment of of the present invention afterwards, migraine healed entirely, recurrence that so far there are no.
Example 3, wear so-and-so, man, 53 years old, people from Guilin, have a headache 7 years, left side temple pain, and with dizziness, tongue body is large, and matter is red, tongue in vain, stringy pulse.After taking 2 courses for the treatment of of the present invention, headache relief, dizzyly reduces, and tongue body is bigger, and tongue is white, stringy pulse; After continuing to take 2 courses for the treatment of, migraine heals entirely, recurrence that so far there are no.
Example 4, beam so-and-so, female, 49 years old, people from Guilin, had a headache 5 years, both sides temple pain, and each headache is 30 minutes, and tongue body is large, and matter is red, and tongue is white, stringy pulse.After taking 2 courses for the treatment of of the present invention, headache relief, tongue body is bigger, and tongue is white, stringy pulse; After continuing to take 1 course for the treatment of, migraine heals entirely, recurrence that so far there are no.
Example 5, Lee so-and-so, man, 58 years old, people from Guilin, have a headache 3 years, often vexed, dreaminess, lustreless complexion, and tongue body is large, and matter is red, tongue in vain, stringy pulse.After taking 1 course for the treatment of of medicine of the present invention, symptom disappears substantially; After taking the 2nd course for the treatment of, migraine heals entirely, follows up a case by regular visits to, and does not recur so far.
Detailed description of the invention
Be described further with embodiment below, but the present invention is not limited to these embodiments.
Embodiment 1
Treat migrainous medicine, be made up of the raw material of following weight portion: 10 parts, Rhizoma Gastrodiae, Fructus Aurantii Immaturus 8 Fen, Fructus Mangifera Indicae root 5 parts, Herba Artemisiae Anomalae 5 parts, Ramulus Cinnamomi 5 parts, Pericarpium Citri Reticulatae 5 parts, Scolopendra 5 parts, Folium Baeckeae 10 parts, Rhizoma Cyperi 10 parts, Radix Platycodonis 14 parts, Radix Angelicae Sinensis 10 parts, Rhizoma Paridis 12 parts, Radix Scutellariae 5 parts, Bulbus Lilii 5 parts, Rhizoma Et Radix Notopterygii 5 parts, 5 parts, Radix Glycyrrhizae.During preparation, by above-mentioned raw materials mixer mill powdered, after ultraviolet sterilization process, after incapsulating, every capsules is containing 0.5 gram of crude drug.
Embodiment 2
Treat migrainous medicine, be made up of the raw material of following weight portion: 20 parts, Rhizoma Gastrodiae, Fructus Aurantii Immaturus 15 Fen, Fructus Mangifera Indicae root 10 parts, Herba Artemisiae Anomalae 10 parts, Ramulus Cinnamomi 10 parts, Pericarpium Citri Reticulatae 10 parts, Scolopendra 10 parts, Folium Baeckeae 1 part, Rhizoma Cyperi 1 part, Radix Platycodonis 6 parts, Radix Angelicae Sinensis 6 parts, Rhizoma Paridis 8 parts, Radix Scutellariae 1 part, Bulbus Lilii 1 part, Rhizoma Et Radix Notopterygii 1 part, 1 part, Radix Glycyrrhizae.During preparation, by above-mentioned raw materials mixer mill powdered, after ultraviolet sterilization process, after incapsulating, every capsules is containing 1 gram of crude drug.
Embodiment 3
Treat migrainous medicine, be made up of the raw material of following weight portion: 10 parts, Rhizoma Gastrodiae, Fructus Aurantii Immaturus 9 Fen, Fructus Mangifera Indicae root 10 parts, Herba Artemisiae Anomalae 6 parts, Ramulus Cinnamomi 8 parts, Pericarpium Citri Reticulatae 10 parts, Scolopendra 5 parts, Folium Baeckeae 6 parts, Rhizoma Cyperi 10 parts, Radix Platycodonis 6 parts, Radix Angelicae Sinensis 8 parts, Rhizoma Paridis 11 parts, Radix Scutellariae 1 part, Bulbus Lilii 3 parts, Rhizoma Et Radix Notopterygii 5 parts, 1 part, Radix Glycyrrhizae.During preparation, by above-mentioned raw materials mixer mill powdered, after ultraviolet sterilization process, after incapsulating, every capsules is containing 0.5 gram of crude drug.
Embodiment 4
Treat migrainous medicine, be made up of the raw material of following weight portion: 15 parts, Rhizoma Gastrodiae, Fructus Aurantii Immaturus 15 Fen, Fructus Mangifera Indicae root 5 parts, Herba Artemisiae Anomalae 8 parts, Ramulus Cinnamomi 9 parts, Pericarpium Citri Reticulatae 5 parts, Scolopendra 8 parts, Folium Baeckeae 9 parts, Rhizoma Cyperi 1 part, Radix Platycodonis 11 parts, Radix Angelicae Sinensis 10 parts, Rhizoma Paridis 8 parts, Radix Scutellariae 3 parts, Bulbus Lilii 5 parts, Rhizoma Et Radix Notopterygii 1 part, 3 parts, Radix Glycyrrhizae.During preparation, by above-mentioned raw materials mixer mill powdered, after ultraviolet sterilization process, after incapsulating, every capsules is containing 0.5 gram of crude drug.
Embodiment 5
Treat migrainous medicine, be made up of the raw material of following weight portion: 18 parts, Rhizoma Gastrodiae, Fructus Aurantii Immaturus 8 Fen, Fructus Mangifera Indicae root 8 parts, Herba Artemisiae Anomalae 10 parts, Ramulus Cinnamomi 5 parts, Pericarpium Citri Reticulatae 8 parts, Scolopendra 10 parts, Folium Baeckeae 2 parts, Rhizoma Cyperi 7 parts, Radix Platycodonis 13 parts, Radix Angelicae Sinensis 6 parts, Rhizoma Paridis 10 parts, Radix Scutellariae 5 parts, Bulbus Lilii 1 part, Rhizoma Et Radix Notopterygii 3 parts, 5 parts, Radix Glycyrrhizae.During preparation, by above-mentioned raw materials mixer mill powdered, after ultraviolet sterilization process, after incapsulating, every capsules is containing 1 gram of crude drug.
Claims (5)
1. treat a migrainous medicine, it is characterized in that, be made up of the raw material of following weight portion:
10 ~ 20 parts, Rhizoma Gastrodiae, Fructus Aurantii Immaturus 8 ~ 15 Fen, Fructus Mangifera Indicae root 5 ~ 10 parts, Herba Artemisiae Anomalae 5 ~ 10 parts, Ramulus Cinnamomi 5 ~ 10 parts, Pericarpium Citri Reticulatae 5 ~ 10 parts, Scolopendra 5 ~ 10 parts, Folium Baeckeae 1 ~ 10 part, Rhizoma Cyperi 1 ~ 10 part, Radix Platycodonis 6 ~ 14 parts, Radix Angelicae Sinensis 6 ~ 10 parts, Rhizoma Paridis 8 ~ 12 parts, Radix Scutellariae 1 ~ 5 part, Bulbus Lilii 1 ~ 5 part, Rhizoma Et Radix Notopterygii 1 ~ 5 part, 1 ~ 5 part, Radix Glycyrrhizae.
2. the migrainous medicine for the treatment of according to claim 1, is characterized in that, the weight portion of described raw material is:
10 parts, Rhizoma Gastrodiae, Fructus Aurantii Immaturus 9 Fen, Fructus Mangifera Indicae root 10 parts, Herba Artemisiae Anomalae 6 parts, Ramulus Cinnamomi 8 parts, Pericarpium Citri Reticulatae 10 parts, Scolopendra 5 parts, Folium Baeckeae 6 parts, Rhizoma Cyperi 10 parts, Radix Platycodonis 6 parts, Radix Angelicae Sinensis 8 parts, Rhizoma Paridis 11 parts, Radix Scutellariae 1 part, Bulbus Lilii 3 parts, Rhizoma Et Radix Notopterygii 5 parts, 1 part, Radix Glycyrrhizae.
3. the migrainous medicine for the treatment of according to claim 1, is characterized in that, the weight portion of described raw material is:
15 parts, Rhizoma Gastrodiae, Fructus Aurantii Immaturus 15 Fen, Fructus Mangifera Indicae root 5 parts, Herba Artemisiae Anomalae 8 parts, Ramulus Cinnamomi 9 parts, Pericarpium Citri Reticulatae 5 parts, Scolopendra 8 parts, Folium Baeckeae 9 parts, Rhizoma Cyperi 1 part, Radix Platycodonis 11 parts, Radix Angelicae Sinensis 10 parts, Rhizoma Paridis 8 parts, Radix Scutellariae 3 parts, Bulbus Lilii 5 parts, Rhizoma Et Radix Notopterygii 1 part, 3 parts, Radix Glycyrrhizae.
4. the migrainous medicine for the treatment of according to claim 1, is characterized in that, the weight portion of described raw material is:
18 parts, Rhizoma Gastrodiae, Fructus Aurantii Immaturus 8 Fen, Fructus Mangifera Indicae root 8 parts, Herba Artemisiae Anomalae 10 parts, Ramulus Cinnamomi 5 parts, Pericarpium Citri Reticulatae 8 parts, Scolopendra 10 parts, Folium Baeckeae 2 parts, Rhizoma Cyperi 7 parts, Radix Platycodonis 13 parts, Radix Angelicae Sinensis 6 parts, Rhizoma Paridis 10 parts, Radix Scutellariae 5 parts, Bulbus Lilii 1 part, Rhizoma Et Radix Notopterygii 3 parts, 5 parts, Radix Glycyrrhizae.
5. the migrainous medicine of the treatment according to any one of Claims 1 to 4, is characterized in that: described medicine is by raw material mixer mill powdered, after ultraviolet sterilization process, incapsulates obtained.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410597553.XA CN104383297A (en) | 2014-10-30 | 2014-10-30 | Medicine for treating migraine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410597553.XA CN104383297A (en) | 2014-10-30 | 2014-10-30 | Medicine for treating migraine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104383297A true CN104383297A (en) | 2015-03-04 |
Family
ID=52601321
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410597553.XA Pending CN104383297A (en) | 2014-10-30 | 2014-10-30 | Medicine for treating migraine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104383297A (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1270043A (en) * | 2000-01-27 | 2000-10-18 | 冀承环 | Medicine for treating hemicrania |
| US20080220084A1 (en) * | 2007-03-09 | 2008-09-11 | Pfantastic Medical Research Institute, Llc | Combination therapy for alleviating pain-related conditions |
| CN102302751A (en) * | 2011-08-19 | 2012-01-04 | 高朱荣 | Chinese medicine for treating migraine |
| CN103845622A (en) * | 2012-12-03 | 2014-06-11 | 李国庆 | Traditional Chinese medicinal preparation for treating headaches |
-
2014
- 2014-10-30 CN CN201410597553.XA patent/CN104383297A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1270043A (en) * | 2000-01-27 | 2000-10-18 | 冀承环 | Medicine for treating hemicrania |
| US20080220084A1 (en) * | 2007-03-09 | 2008-09-11 | Pfantastic Medical Research Institute, Llc | Combination therapy for alleviating pain-related conditions |
| CN102302751A (en) * | 2011-08-19 | 2012-01-04 | 高朱荣 | Chinese medicine for treating migraine |
| CN103845622A (en) * | 2012-12-03 | 2014-06-11 | 李国庆 | Traditional Chinese medicinal preparation for treating headaches |
Non-Patent Citations (3)
| Title |
|---|
| 杜同仿: "沈炎南教授治疗偏正头痛经验", 《新中医》 * |
| 陈绍红等: "偏头痛的用药规律探讨", 《中华中医药杂志》 * |
| 魏静等: ""治偏汤"治疗偏头痛56例体会", 《新疆中医药》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101380436B (en) | Traditional Chinese medicine composition for treating chronic pharyngitis | |
| CN103655989A (en) | Traditional Chinese medicine for external use for treating rheumatic arthritis | |
| CN103356968B (en) | Traditional Chinese medicine composition for treating endometriosis | |
| CN102697898A (en) | Medicament for regulating endocrine and curing dysmenorrheal, mammary gland hyperplasia and breast dysplasia | |
| CN102961529B (en) | Traditional Chinese medicine composition for treating coronary heart disease | |
| CN102451449A (en) | Capsule for warming channel and dispelling cold | |
| CN104173727A (en) | Medicine for treating toothache | |
| CN104383297A (en) | Medicine for treating migraine | |
| CN105617042A (en) | Traditional Chinese medicine composition for treating headache | |
| CN105169254A (en) | Traditional Chinese medicine decoction for treating chronic hepatitis | |
| CN103768328A (en) | Medicinal magnetic plaster for treating tumors | |
| CN102343039A (en) | Drug for treating skin diseases such as psoriasis, leucoderma, ichthyosis, eczema and the like | |
| CN104800599A (en) | Traditional Chinese medicinal composition for treating deficiency of kidney-yin | |
| CN105012572A (en) | Composition traditional Chinese medicine for treating five kinds of retardation of infants | |
| CN104042927A (en) | Traditional Chinese medicine composition for treating senile dementia | |
| CN105031181A (en) | Medicinal liquor for treating rheumatic arthralgia and preparation method thereof | |
| CN104042833A (en) | Traditional Chinese medicine composition for treating five kinds of children's retardation | |
| CN104383298B (en) | A traditional Chinese medicine composition for promoting fracture healing | |
| CN104027615A (en) | Traditional Chinese medicine composition for treating vertigo | |
| CN104147503A (en) | Traditional Chinese medicinal composition for treating cervical spondylosis and preparation method thereof | |
| CN100398128C (en) | Medicine for treating cervical vertebra disease, lumbar intervertebral disk protrusion, bone fracture and crush fracture | |
| CN102058797A (en) | Chinese medicine for treating cerebral hemorrhage and preparation method thereof | |
| CN1931260B (en) | Hyperlipemia treating oral liquid | |
| CN105596482A (en) | Waist sprain treating traditional Chinese medicine formula | |
| CN105012706A (en) | Traditional Chinese medicine composition for treating Alzheimer's diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150304 |
|
| WD01 | Invention patent application deemed withdrawn after publication |